Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Trimerization profile of type IV collagen COL4A5 exon deletion in X-linked Alport syndrome.
Clin Exp Nephrol. 2024 Apr 24. doi: 10.1007/s10157-024-02503-9. Online ahead of print.
Clin Exp Nephrol. 2024.
PMID: 38658441
CyclosporinA Derivative as Therapeutic Candidate for Alport Syndrome by Inducing Mutant Type IV Collagen Secretion.
Kuwazuru J, Suico MA, Omachi K, Kojima H, Kamura M, Kaseda S, Kawahara T, Hitora Y, Kato H, Tsukamoto S, Wada M, Asano T, Kotani S, Nakajima M, Misumi S, Sannomiya Y, Horizono J, Koyama Y, Owaki A, Shuto T, Kai H.
Kuwazuru J, et al. Among authors: horizono j.
Kidney360. 2023 Jul 1;4(7):909-917. doi: 10.34067/KID.0000000000000134. Epub 2023 May 5.
Kidney360. 2023.
PMID: 37143203
Free PMC article.
Item in Clipboard
Novel Keap1-Nrf2 Protein-Protein Interaction Inhibitor UBE-1099 Ameliorates Progressive Phenotype in Alport Syndrome Mouse Model.
Kaseda S, Sannomiya Y, Horizono J, Kuwazuru J, Suico MA, Ogi S, Sasaki R, Sunamoto H, Fukiya H, Nishiyama H, Kamura M, Niinou S, Koyama Y, Nara F, Shuto T, Onuma K, Kai H.
Kaseda S, et al. Among authors: horizono j.
Kidney360. 2021 Dec 1;3(4):687-699. doi: 10.34067/KID.0004572021. eCollection 2022 Apr 28.
Kidney360. 2021.
PMID: 35721612
Free PMC article.
Item in Clipboard
Cite
Cite